157669-75-5

Upstream product

• 176848-50-3 2-((R)-16-Hydroxy-heptadecyl)-6-methoxy-benzoic acid 
• 73274-87-0 3-hydroxy-7-methoxy-3H-isobenzofuran-1-one 
• 81819-07-0 12-bromo-1-dodecaldehyde 
• 176848-48-9 (E)-(R)-16-Bromo-hexadec-4-en-2-ol 

Downstream Products

• 181624-34-0 2-Benzyloxy-6-[(R)-16-((2S,3S,4S,5R,6R)-3,4,5-tris-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-2-yloxy)-heptadecyl]-benzoic acid benzhydryl ester 
• 181624-36-2 2-Benzyloxy-6-[(R)-16-((2R,3S,4S,5R,6R)-3,4,5-tris-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-2-yloxy)-heptadecyl]-benzoic acid benzhydryl ester 
• 176848-52-5 2-Benzyloxy-6-((R)-16-hydroxy-heptadecyl)-benzoic acid benzhydryl ester 
• 176848-51-4 2-Hydroxy-6-((R)-16-hydroxy-heptadecyl)-benzoic acid benzhydryl ester 

Relevant academic research and scientific papers

Total synthesis of deacetyl-caloporoside, a novel inhibitor of the GABA(A) receptor ion channel

The total synthesis of deacetyl-caloporoside (1) which contains a β-D-mannopyranoside unit has been accomplished by coupling of the disaccharide-like segment derived from methyl α-D-mannopyranoside, with the hydroxyheptadecyl salicylic acid segment. The biological activity of 1 has also been evaluated.